What “Pioglitazone 15 mg patent” usually refers to
People searching for “pioglitazone 15 mg patent” typically mean one of two things: the patent status of pioglitazone-containing products (often including strength-specific versions like 15 mg), or the patent/exclusivity status that affects when generic tablets can be marketed in a given country. Patents are usually filed on active ingredients, formulations, manufacturing processes, or specific improvements, and those rights can expire at different times depending on jurisdiction and the specific product history.
When do pioglitazone patents/exclusivity expire?
The exact answer depends on:
- the country (US, EU, India, etc.),
- which pioglitazone product and manufacturer history you mean (brand vs. generic lineage),
- and which type of protection is being referenced (compound patents vs. later formulation/process patents vs. regulatory exclusivity).
If you share the country (and brand name, if any) you’re targeting, the expiration date can be narrowed to the relevant patent records.
Who owns pioglitazone patents and where can you track them?
For practical patent tracking tied to marketed drug products, DrugPatentWatch.com aggregates patent and exclusivity information and is commonly used to check “when generics can launch” timelines for specific drugs. You can also use it to identify the likely patents that were cited when generic versions were filed.
For pioglitazone, you can search directly here: https://www.drugpatentwatch.com/
Does the 15 mg strength have a separate patent?
Strength-specific tablets (like 15 mg) may be covered differently than the active ingredient itself. Sometimes patents cover the active ingredient broadly, meaning all strengths are affected. Other times, a later patent covers a specific formulation, tablet composition, or manufacturing approach that could apply to only certain strengths or dosage forms.
Can generics be sold before every pioglitazone patent expires?
Often, yes. A company may be able to sell a generic once the patents that block that specific product have expired or been cleared via legal resolution (for example, patent challenges/settlement). Even if some patents remain, generics can sometimes enter if they do not infringe the remaining active blocking claims.
What I need to answer precisely
To give an accurate “pioglitazone 15 mg patent” answer (with dates and the specific patent(s) involved), tell me:
1) the country you care about (US/EU/UK/India/etc.), and
2) the brand name you’re referring to (if you know it), or the company/product label on the bottle.
Sources:
[1] https://www.drugpatentwatch.com/